Loading…
Reported covered position: Rep. Tom Tancredo, Leg. Asst.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Workplace Violence Prevention for Health Care and Social Service Workers Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues related to OSHA and hospitals. Monitored H.R. 842, Protecting the Right to Organize Act. H.R. 1195, Workplace Violence Prevention for Health Care and Social Service Workers Act.
Implementation issues related to P.L. 116-139, the Paycheck Protection Program and Healthcare Enhancement Act; funding issues related to antibody & antigen tests for COVID-19; implementation issues related to H.R. 133, the Consolidated Appropriations Act of 2021, pertaining to COVID testing. P.L. 117-2, the American Rescue Plan, as it relates to COVID testing.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored P.L. 117-2, the American Rescue Plan, as it relates to therapeutics and the supply chain.
Monitored FY'21 Budget Resolution.
Source: Senate LDA
| BAXTER HEALTHCARE CORPORATION |
| 31 |
| 2013–2021 |
| CLEVELAND CLINIC FOUNDATION | 31 | 2013–2021 |
| SMITH & NEPHEW INC | 28 | 2014–2021 |
| BLUEBIRD BIO | 21 | 2016–2021 |
| MERCK & CO., INC. | 17 | 2015–2018 |
| SHIRE PHARMACEUTICALS LLC | 14 | 2016–2018 |
| CSL BEHRING LLC | 13 | 2019–2021 |
| JOHNSON & JOHNSON SERVICES, INC. | 11 | 2019–2021 |
| EHEALTH | 10 | 2016–2018 |
| METROPOLITAN LIFE INSURANCE COMPANY | 10 | 2014–2019 |
| SIDECAR HEALTH, INC. | 9 | 2019–2021 |
| WALMART INC | 9 | 2014–2018 |
| ACCENTURE LLP | 8 | 2019–2021 |
| CUBIST PHARMACEUTICALS, INC. | 8 | 2013–2014 |
| MYRIAD GENETICS INC | 8 | 2019–2021 |
| OWENS & MINOR, INC. | 8 | 2013–2015 |
| SONITUS MEDICAL INC. | 8 | 2013–2014 |
| THERANOS, INC. | 7 | 2015–2016 |
| BIONX MEDICAL TECHNOLOGIES, INC. | 6 | 2016–2017 |
| BAXALTA INC. | 5 | 2015–2016 |
| GENERAL MOTORS LLC | 5 | 2013–2015 |
| ORTHO-CLINICAL DIAGNOSTICS, INC. | 5 | 2020–2021 |
| UNITEDHEALTH GROUP, INC. | 5 | 2015 |
| HOSPICE ACTION NETWORK | 4 | 2014–2017 |
| JUUL LABS, INC | 4 | 2019–2020 |
| NOVARTIS CORPORATION | 4 | 2013–2014 |
| SPACEX | 4 | 2013–2014 |
| AMERICAN SOCIETY OF ANESTHESIOLOGISTS | 3 | 2020–2021 |
| EXXON MOBIL CORPORATION | 3 | 2013–2014 |
| GILEAD SCIENCES, INC. | 2 | 2020 |
| CASE NEW HOLLAND, INC. AND ITS AFFILIATES | 1 | 2013 |
| MERCHANTS PAYMENTS COALITION INC | 1 | 2017 |
| MISSION HEALTH | 1 | 2014 |
| ORACLE CORPORATION | 1 | 2021 |
| SEND RELIEF, INC. | 1 | 2017 |
To prevent across-the-board direct spending cuts, and for other purposes.
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding telehealth. Monitored issues regarding PPS exempt hospitals. P.L. 117-2, the American Rescue Plan, as it relates to sequestration relief. H.R. 1868, Medicare Sequester Bill, S. 748, Medicare Sequester Relief Act, as it relates to sequestration relief for hospitals.
To prevent across-the-board direct spending cuts, and for other purposes.
Client: UCB, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to COVID-19 and access to Part B drugs; monitored issues related to the Most Favored Nation (MFN) and rebate rule; issues related to reimbursement of self-administered drugs; monitored issues related to the importation of prescription drugs; issues related to Part D drugs and protected classes. Monitored P.L. 117-2, the American Rescue Plan and issues related to drug pricing. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
To prevent across-the-board direct spending cuts, and for other purposes.
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to Medicare Advantage Plans and issues related to telehealth. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
To prevent across-the-board direct spending cuts, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to disposable negative pressure wound therapy; issues related to teleheath; monitored P.L. 117-2, the American Rescue Plan. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
To prevent across-the-board direct spending cuts, and for other purposes.
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund and sequestration relief. H.R. 1868, Medicare Sequester Bill, S. 748, Medicare Sequester Relief Act, as it relates to sequestration relief for hospitals.
S. 464 / H.R. 2163, the Safe Step Act and issues related to step therapy.
Monitored H.R. 842, Protecting the Right to Organize Act of 2021. Monitored H.R. 447, The National Apprenticeship Act of 2021. Issues related to OSHA and work health and safety.
Monitored issues related to drug shortages. P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund and COVID relief funding. S. 168 / H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act.
Protecting the Right to Organize Act of 2021
Client: ACCENTURE LLP · Firm: THE NICKLES GROUP, LLC
Monitored H.R. 842, Protecting the Right to Organize Act of 2021. Monitored H.R. 447, The National Apprenticeship Act of 2021. Issues related to OSHA and work health and safety.
Protecting the Right to Organize Act of 2021
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues related to OSHA and hospitals. Monitored H.R. 842, Protecting the Right to Organize Act. H.R. 1195, Workplace Violence Prevention for Health Care and Social Service Workers Act.
Monitored issues related to drug shortages. P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund and COVID relief funding. S. 168 / H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act.
S. 464 / H.R. 2163, the Safe Step Act and issues related to step therapy.
Issues related to disposable negative pressure wound therapy; issues related to teleheath; monitored P.L. 117-2, the American Rescue Plan. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
Medicare Sequester Relief Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund and sequestration relief. H.R. 1868, Medicare Sequester Bill, S. 748, Medicare Sequester Relief Act, as it relates to sequestration relief for hospitals.
Issues related to COVID-19 and access to Part B drugs; monitored issues related to the Most Favored Nation (MFN) and rebate rule; issues related to reimbursement of self-administered drugs; monitored issues related to the importation of prescription drugs; issues related to Part D drugs and protected classes. Monitored P.L. 117-2, the American Rescue Plan and issues related to drug pricing. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
Monitored issues related to Medicare Advantage Plans and issues related to telehealth. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
Medicare Sequester Relief Act
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding telehealth. Monitored issues regarding PPS exempt hospitals. P.L. 117-2, the American Rescue Plan, as it relates to sequestration relief. H.R. 1868, Medicare Sequester Bill, S. 748, Medicare Sequester Relief Act, as it relates to sequestration relief for hospitals.
Consolidated Appropriations Act, 2020
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
Workplace Violence Prevention for Health Care and Social Service Workers Act
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Workplace Violence Prevention for Health Care and Social Service Workers Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues related to 42 CFR Part 2; monitored issues regarding drug pricing; issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Workplace Violence Prevention for Health Care and Social Service Workers Act
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Consolidated Appropriations Act, 2021
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to provider relief fund and issues related to surprise medical billing.
Consolidated Appropriations Act, 2021
Client: MYRIAD GENETICS, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to laboratory developed tests and reimbursement; issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to the 2020 OPPS rule specifically related to packaging policy. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to surprise medical billing. Issues related to provider relief fund.
Consolidated Appropriations Act, 2021
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth; issues related to the Most Favored Nation (MFN) and drug rebate rule. H.R. 133, the Consolidated Appropriations Act of 2021, issues related to health extenders and telehealth.
Consolidated Appropriations Act, 2021
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to rural anesthesiology; issues related to scope of practice; issues related to implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COVID-19 in anesthesiology; H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to COVID relief and surprise medical billing.
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021; monitored issues related to the Most Favored Nation (MFN) rule.
Consolidated Appropriations Act, 2021
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines; issues related to H.R. 133, the Consolidated Appropriations Act of 2021, including vaccines, ASP reporting and liability. Monitored issues related to Most Favored Nation (MFN) rule and drug rebates.
Consolidated Appropriations Act, 2021
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, including issues related to sequestration relief, rural hospitals, provider relief funding and Medicaid DSH payments. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Consolidated Appropriations Act, 2021
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines; issues related to H.R. 133, the Consolidated Appropriations Act of 2021, including vaccines, ASP reporting and liability. Monitored issues related to Most Favored Nation (MFN) rule and drug rebates.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Consolidated Appropriations Act, 2021
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, issues related to health extenders and telehealth.
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Consolidated Appropriations Act, 2021
Client: MYRIAD GENETICS, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to S. 3404, VALID Act. Monitored issues related to the implementation of P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act; issues related to EKRA; H.R. 925 / H.R. 8406, The HEROES Act, issues related to COVID-19 testing and provider relief. H.R. 133, the Consolidated Appropriations Act of 2021, including surprise medical bill and COVID-19 testing.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Consolidated Appropriations Act, 2021
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
Issues related to S.1895, the Lower Health Care Costs Act of 2019, and issues related to transparency. Issues related to H.R. 133, the Consolidated Appropriations Act of 2021 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act, including COVID-19 testing and surprise medical billing.
Consolidated Appropriations Act, 2021
Client: ORTHO-CLINICAL DIAGNOSTICS, INC. · Firm: THE NICKLES GROUP, LLC
Implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); funding issues related to antibody & antigen tests for COVID-19; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to COVID testing.
Consolidated Appropriations Act, 2021
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
Most Favored Nation (MFN) rule & drug rebates; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to COVID-19, and the reimbursement of self-administered drugs.
Consolidated Appropriations Act, 2021
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
H.R. 7839, Continuing Access to In-Home IVIG Act. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act, including access to IVIG and telehealth. Issues related to Medicare Advantage plans.
Consolidated Appropriations Act, 2021
Client: AMERICAN DENTAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; issues involving implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to the provider relief fund; issues involving H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 1379, Ensuring Lasting Smiles Act. H.R. 133, Consolidated Appropriations Act of 2021, as it relates to surprise billing, the provider relief fund, testing, tracing and vaccines. Issues concerning provider relief fund disbursements.
Consolidated Appropriations Act, 2021
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, including issues related to sequestration relief, rural hospitals, provider relief funding and Medicaid DSH payments. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Consolidated Appropriations Act, 2021
Client: SMITH & NEPHEW, INC. · Firm: THE NICKLES GROUP, LLC
H.R. 8624, Protecting Access to Innovation During COVID-19 Act; H.R. 7127, and issues related to disposable negative pressure wound therapy; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); monitored issues related to the Most Favored Nation (MFN) rule. H.R. 133, the Consolidated Appropriations Act of 2021, and issues related to health extenders.
Consolidated Appropriations Act, 2021
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to prescription drug pricing. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act, as it relates to accelerated payments and Medicaid DSH. H.R. 7791, Value in Health Care Act of 2020. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to provider funding. H.R. 133, The Consolidated Appropriations Act of 2021 including provider relief funding, Medicaid DSH, surprise billing, sequestration relief, testing, vaccines and liability reform.
Issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the COVID-19 access to Part B drugs; issues related to the Most Favored Nation (MFN) and rebate rule; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to reimbursement of self-administered drugs; issues related to the importation of prescription drugs.
Consolidated Appropriations Act, 2021
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. H.R. 2710 / S.2751, Patient Access to ESRD New Innovative Devices Act, S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the strategic national stockpile. Issues related to home dialysis and the Presidents Advancing American Kidney Health Initiative (AAKHI), and the ESRD Treatment Choices model. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 925 / H.R. 8406, The HEROES Act. Monitored S. 4317, SAFE TO WORK Act. Monitored S. 4322, Safely Back to School and Back to Work Act. H.R. 133, The Consolidated Appropriations Act of 2021.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Consolidated Appropriations Act, 2021
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to provider relief fund and issues related to surprise medical billing.
Consolidated Appropriations Act, 2021
Client: GILEAD SCIENCES, INC. · Firm: THE NICKLES GROUP, LLC
Monitored issues related to COVID relief including H.R. 925 / H.R. 8406, The HEROES Act. Monitored H.R. 133, the Consolidated Appropriations Act of 2021.
Ensuring Lasting Smiles Act
Client: AMERICAN DENTAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues regarding access to dental services. Monitored H.R. 1835, Consensual Donation and Research Integrity Act of 2019. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. S.2740 / H.R.3443, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019. Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136, as it relates to over-the-counter monograph safety and surprise billing. Monitored issues related to Indian Health Services. H.R.1379, the Ensuring Lasting Smiles Act. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act.
Ensuring Lasting Smiles Act
Client: AMERICAN DENTAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; issues involving implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to the provider relief fund; issues involving H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 1379, Ensuring Lasting Smiles Act. H.R. 133, Consolidated Appropriations Act of 2021, as it relates to surprise billing, the provider relief fund, testing, tracing and vaccines. Issues concerning provider relief fund disbursements.
Ensuring Lasting Smiles Act
Client: AMERICAN DENTAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; issues involving implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to the provider relief fund; issues involving H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 1379, Ensuring Lasting Smiles Act.
Medicare Dental, Vision, and Hearing Benefit Act of 2019
Client: AMERICAN DENTAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues regarding dental services in Medicare. Monitored H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act. H.R. 3, the Lower Drug Costs Now Act. Issues related to H.R.3935, the Protecting Patients Transportation to Care Act.
Consensual Donation and Research Integrity Act of 2019
Client: AMERICAN DENTAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues regarding access to dental services. Monitored H.R. 1835, Consensual Donation and Research Integrity Act of 2019. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. S.2740 / H.R.3443, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019. Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136, as it relates to over-the-counter monograph safety and surprise billing. Monitored issues related to Indian Health Services. H.R.1379, the Ensuring Lasting Smiles Act. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act.
Further Consolidated Appropriations Act, 2020
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices. Monitored H.R. 2113, Prescription Drug STAR Act, as it relates to sample device products.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
More Efficient Tools to Realize Information for Consumers Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis. Coronavirus Aid, Relief & Economic Security Act "CARES Act," P.L. 116-136, as it relates to home dialysis and urgent start dialysis.
More Efficient Tools to Realize Information for Consumers Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis and the Presidents Advancing American Kidney Health initiative (AAKHI). Issues regarding urgent start dialysis.
More Efficient Tools to Realize Information for Consumers Act
Client: CSL BEHRING LLC · Firm: THE NICKLES GROUP, LLC
Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
More Efficient Tools to Realize Information for Consumers Act
Client: CSL BEHRING LLC · Firm: THE NICKLES GROUP, LLC
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies.
Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; issues involving implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to the provider relief fund; issues involving H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 1379, Ensuring Lasting Smiles Act. H.R. 133, Consolidated Appropriations Act of 2021, as it relates to surprise billing, the provider relief fund, testing, tracing and vaccines. Issues concerning provider relief fund disbursements.
Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency. Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues regarding access to dental services. Monitored H.R. 1835, Consensual Donation and Research Integrity Act of 2019. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. S.2740 / H.R.3443, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019. Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136, as it relates to over-the-counter monograph safety and surprise billing. Monitored issues related to Indian Health Services. H.R.1379, the Ensuring Lasting Smiles Act. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to testing.
Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; issues involving implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to the provider relief fund; issues involving H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 1379, Ensuring Lasting Smiles Act.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to COVID-19 testing.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: AMERICAN DENTAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues regarding access to dental services. Monitored H.R. 1835, Consensual Donation and Research Integrity Act of 2019. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. S.2740 / H.R.3443, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019. Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136, as it relates to over-the-counter monograph safety and surprise billing. Monitored issues related to Indian Health Services. H.R.1379, the Ensuring Lasting Smiles Act. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. H.R. 2710 / S.2751, Patient Access to ESRD New Innovative Devices Act, S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the strategic national stockpile. Issues related to home dialysis and the Presidents Advancing American Kidney Health Initiative (AAKHI), and the ESRD Treatment Choices model. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 925 / H.R. 8406, The HEROES Act. Monitored S. 4317, SAFE TO WORK Act. Monitored S. 4322, Safely Back to School and Back to Work Act. H.R. 133, The Consolidated Appropriations Act of 2021.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis. Coronavirus Aid, Relief & Economic Security Act "CARES Act," P.L. 116-136, as it relates to home dialysis and urgent start dialysis.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health initiative (AAKHI). Issues regarding urgent start dialysis.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home. Coronavirus Aid, Relief & Economic Security Act "CARES Act," P.L. 116-136, as it relates to home dialysis and urgent start dialysis.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis and the Presidents Advancing American Kidney Health initiative (AAKHI). Issues regarding urgent start dialysis.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. H.R. 2710 / S.2751, Patient Access to ESRD New Innovative Devices Act, S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the strategic national stockpile. Issues related to home dialysis and the Presidents Advancing American Kidney Health Initiative (AAKHI), and the ESRD Treatment Choices model. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 925 / H.R. 8406, The HEROES Act. Monitored S. 4317, SAFE TO WORK Act. Monitored S. 4322, Safely Back to School and Back to Work Act.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710 / S. 2751, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health Initiative (AAKHI).
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710 / S. 2751, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health Initiative (AAKHI).
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored issues related to drug pricing. Issues related to the corona virus.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Issues related to the Executive Order on Lowering Drug Prices by Putting America First. H.R. 7839, Continuing Access to In-Home IVIG Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
Issues related to S. 2543, The Prescription Drug Pricing Reduction Act of 2019 and including Part D and Part B; issues related to the IPI CMMI demonstration; monitored issues related to H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; issues related to the reimbursement of CAR-T therapy.
Elijah E. Cummings Lower Drug Costs Now Act
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to the safe harbor protection. S. 2543 The Prescription Drug Pricing Reduction Act of 2019; issues related to Medicare Advantage; issues related to Price Transparency; issues related to H.R. 3, the Elijah E. Cummings Lower Cost Act of 2019.
S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to the reimbursement of Part B and D drugs; and H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN DENTAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues regarding dental services in Medicare. Monitored H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act. H.R. 3, the Lower Drug Costs Now Act. Issues related to H.R.3935, the Protecting Patients Transportation to Care Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: SMITH & NEPHEW, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: CSL BEHRING LLC · Firm: THE NICKLES GROUP, LLC
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
Elijah E. Cummings Lower Drug Costs Now Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to biosimilars; S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to price transparency; issues related to rural hospitals; issues related to Medicaid DSH payments; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). S. 2543, The Prescription Drug Pricing Reduction Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Issues related to drug pricing including S. 2543 Prescription Drug pricing Act and issues related to value based payment over time; H.R. 5882 the GENE Therapy Payment Act; H.R. 3 Elijah E. Cummings lower drug costs act; issues related to Medicaid Best Price and AMP reporting. Issues related to H.R. 3935, the Protecting Patients Transportation to Care Act.
To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.
Client: AMERICAN DENTAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues regarding access to dental services. Monitored H.R. 1835, Consensual Donation and Research Integrity Act of 2019. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. S.2740 / H.R.3443, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019. Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136, as it relates to over-the-counter monograph safety and surprise billing. Monitored issues related to Indian Health Services. H.R.1379, the Ensuring Lasting Smiles Act. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act.
Monitored Most Favored Nation (MFN) rule and drug rebate rule. Issues related to COVID-19 and issues related to the reimbursement of self-administered drugs. Monitored P.L. 117-2, the American Rescue Plan, as it relates to drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored issues related to drug shortages. P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund and COVID relief funding. S. 168 / H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act.
Issues regarding telehealth. Monitored issues regarding PPS exempt hospitals. P.L. 117-2, the American Rescue Plan, as it relates to sequestration relief. H.R. 1868, Medicare Sequester Bill, S. 748, Medicare Sequester Relief Act, as it relates to sequestration relief for hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MYRIAD GENETICS, INC. via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored issues related to the regulation of pharmacogenomic tests.
Issues related to access to depression treatments for veterans. Issues related to implementation of P.L. 116-171, Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019.
Monitored P.L. 117-2, the American Rescue Plan, as it relates to COVID-19 testing and provider relief.
Issues related to access to depression treatments for veterans.
Monitored issues related to laboratory developed tests and reimbursement. Monitored P.L. 117-2, the American Rescue Plan.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACCENTURE LLP via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored H.R. 842, Protecting the Right to Organize Act of 2021. Monitored H.R. 447, The National Apprenticeship Act of 2021. Issues related to OSHA and work health and safety.
Monitored P.L.117-2, the American Rescue Plan, as it relates to contact tracing and testing for COVID-19.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
AMERICAN DENTAL ASSOCIATION via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Issues regarding access to dental services. Issues involving implementation of P.L.116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to the provider relief fund. Issues concerning provider relief fund disbursements. Monitored issues related to expansion of the Affordable Care Act; P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund, PPE testing and vaccines.
Issues regarding dental services in Medicare. Monitored issues regarding the expansion of Medicaid. Issues regarding Medicaid coverage of non-emergency transportation to medically necessary services.
Filing targets: Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
UCB, INC. via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored FY'21 Budget Resolution.
Issues related to COVID-19 and access to Part B drugs; monitored issues related to the Most Favored Nation (MFN) and rebate rule; issues related to reimbursement of self-administered drugs; monitored issues related to the importation of prescription drugs; issues related to Part D drugs and protected classes. Monitored P.L. 117-2, the American Rescue Plan and issues related to drug pricing. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
S. 464 / H.R. 2163, the Safe Step Act and issues related to step therapy.
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored issues related to P.L. 117-2, the American Rescue Plan, as it relates to COVID relief.
Issues related to Medicare coverage of vaccines. Monitored P.L. 117-2, the American Rescue Plan, as it relates to drug pricing provisions and COVID relief and issues related to maternal health.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored FY'21 Budget Resolution.
Monitored issues related to FDA approval of breakthrough therapies. Monitored P.L. 117-2, the American Rescue Plan.
Issues related to value based payment over time. Issues related to rulemaking supporting VBP arrangements. Monitored issues related to P.L. 117-2, the American Rescue Plan, as it relates to drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored P.L. 117-2, the American Rescue Plan, including issues related to COVID-19 testing and insurance coverage expansion.
Monitored FY'21 Budget Resolution.
Monitored issues related to Medicare Advantage Plans and issues related to telehealth. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORACLE CORPORATION via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Issues related to IT modernization and data centers.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Issues related to consumer directed healthcare and expanded access.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SMITH & NEPHEW, INC. via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Issues related to disposable negative pressure wound therapy; issues related to teleheath; monitored P.L. 117-2, the American Rescue Plan. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
Monitored FY'21 Budget Resolution.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored FY'21 Budget Resolution.
P.L. 117-2, the American Rescue Plan, as it relates to COVID relief.
Issues pertaining to administration of anesthesia services to veterans.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
ORTHO-CLINICAL DIAGNOSTICS, INC. via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Implementation issues related to P.L. 116-139, the Paycheck Protection Program and Healthcare Enhancement Act; funding issues related to antibody & antigen tests for COVID-19; implementation issues related to H.R. 133, the Consolidated Appropriations Act of 2021, pertaining to COVID testing. P.L. 117-2, the American Rescue Plan, as it relates to COVID testing.
Filing targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Issues involving promoting plasma donation and convalescent plasma donation. Monitored issues related to drug pricing. Monitored P.L. 117-2, the American Rescue Plan.
Monitored issues related to home infusion and plasma therapies.
Monitored FY'21 Budget Resolution.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Issues related to OSHA and hospitals. Monitored H.R. 842, Protecting the Right to Organize Act. H.R. 1195, Workplace Violence Prevention for Health Care and Social Service Workers Act.
P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund.
Monitored FY'21 Budget Resolution.
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2021 · first_quarter · Q1
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. Issues involving drug shortages. Issues regarding the strategic national stockpile. Issues related to home dialysis. Monitored P.L. 117-2, The American Rescue Plan.
Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. Issues regarding dialysis in the home.
Monitored FY'21 Budget Resolution.
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2021 · first_quarter · 1T
Issues related to Medicare Advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth; issues related to the Most Favored Nation (MFN) and drug rebate rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines; issues related to H.R. 133, the Consolidated Appropriations Act of 2021, including vaccines, ASP reporting and liability. Monitored issues related to Most Favored Nation (MFN) rule and drug rebates.
Monitored issues related to S. 1895, Lower Health Care Costs Act of 2019; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines; issues related to H.R. 133, the Consolidated Appropriations Act of 2021, including vaccines, ASP reporting and liability. Monitored issues related to Most Favored Nation (MFN) rule and drug rebates.
Monitored issues related to S. 1895, Lower Health Care Costs Act of 2019; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the COVID-19 access to Part B drugs; issues related to the Most Favored Nation (MFN) and rebate rule; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to reimbursement of self-administered drugs; issues related to the importation of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to FDA approval of breakthrough therapies.
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021; monitored issues related to the Most Favored Nation (MFN) rule.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
H.R. 133, the Consolidated Appropriations Act of 2021, including issues related to sequestration relief, rural hospitals, provider relief funding and Medicaid DSH payments. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues related to OSHA and hospitals.
H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to provider relief fund and issues related to surprise medical billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SMITH & NEPHEW, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 8624, Protecting Access to Innovation During COVID-19 Act; H.R. 7127, and issues related to disposable negative pressure wound therapy; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); monitored issues related to the Most Favored Nation (MFN) rule. H.R. 133, the Consolidated Appropriations Act of 2021, and issues related to health extenders.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Most Favored Nation (MFN) rule & drug rebates; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to COVID-19, and the reimbursement of self-administered drugs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORTHO-CLINICAL DIAGNOSTICS, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); funding issues related to antibody & antigen tests for COVID-19; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to COVID testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MYRIAD GENETICS, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
S 3404, VALID Act and regulation of pharmacogenomic tests.
Issues related to laboratory developed tests and reimbursement; issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to the 2020 OPPS rule specifically related to packaging policy. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to surprise medical billing. Issues related to provider relief fund.
Issues related to access for veterans to pharmacogenomic testing for mental health. Issues related to implementation of S. 785, Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019.
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth; issues related to the Most Favored Nation (MFN) and drug rebate rule. H.R. 133, the Consolidated Appropriations Act of 2021, issues related to health extenders and telehealth.
H.R. 133, the Consolidated Appropriations Act of 2021, issues related to health extenders and telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Monitored issues related to COVID relief including H.R. 925 / H.R. 8406, The HEROES Act. Monitored H.R. 133, the Consolidated Appropriations Act of 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Monitored issues related to drug pricing and drug shortages. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act; issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act. H.R. 8283, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act.
Monitored issues related to prescription drug pricing. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act, as it relates to accelerated payments and Medicaid DSH. H.R. 7791, Value in Health Care Act of 2020. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to provider funding. H.R. 133, The Consolidated Appropriations Act of 2021 including provider relief funding, Medicaid DSH, surprise billing, sequestration relief, testing, vaccines and liability reform.
AMERICAN DENTAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; issues involving implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to the provider relief fund; issues involving H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 1379, Ensuring Lasting Smiles Act. H.R. 133, Consolidated Appropriations Act of 2021, as it relates to surprise billing, the provider relief fund, testing, tracing and vaccines. Issues concerning provider relief fund disbursements.
Issues regarding dental services in Medicare. Monitored H.R. 3935, Protecting Patients Transportation to Care Act.
ACCENTURE LLP via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to workforce training.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 133, the Consolidated Appropriations Act of 2021, including issues related to sequestration relief, rural hospitals, provider relief funding and Medicaid DSH payments. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to provider relief fund and issues related to surprise medical billing.
Issues related to OSHA and hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to rural anesthesiology; issues related to scope of practice; issues related to implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COVID-19 in anesthesiology; H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to COVID relief and surprise medical billing.
Issues pertaining to administration of anesthesia services for veterans.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. H.R. 2710 / S.2751, Patient Access to ESRD New Innovative Devices Act, S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the strategic national stockpile. Issues related to home dialysis and the Presidents Advancing American Kidney Health Initiative (AAKHI), and the ESRD Treatment Choices model. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 925 / H.R. 8406, The HEROES Act. Monitored S. 4317, SAFE TO WORK Act. Monitored S. 4322, Safely Back to School and Back to Work Act. H.R. 133, The Consolidated Appropriations Act of 2021.
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710 / S. 2751, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health Initiative (AAKHI).
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to consumer directed healthcare and expanded access.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 7839, Continuing Access to In-Home IVIG Act. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act, including access to IVIG and telehealth. Issues related to Medicare Advantage plans.
Issues related to S.1895, the Lower Health Care Costs Act of 2019, and issues related to transparency. Issues related to H.R. 133, the Consolidated Appropriations Act of 2021 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act, including COVID-19 testing and surprise medical billing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the COVID-19 access to Part B drugs; issues related to the Executive Order on Lowering Drug Prices by Putting America First; issues related to the importation of prescription drugs.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related to S. 1895, Lower Health Care Costs Act of 2019; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality; H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and issues related to vaccines and liability; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Monitored issues related to H.R. 7120, the George Floyd Justice in Policing Act, and S. 3985, the JUSTICE Act.
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related to the The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; monitored issues related to COVID relief including H.R. 925 / H.R. 8406, The HEROES Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act.
Issues related to OSHA and hospitals.
Monitored issues related to price transparency; issues related to rural hospitals; issues related to Medicaid DSH payments; implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to the reimbursement of CAR-T therapy; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; issues related to prescription drug research and development and product life cycles; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · third_quarter · 3A
Issues related to Medicare Advantage and issues related to price transparency. Issues related to the Executive Order on Lowering Drug Prices by Putting America First. Issues related to H.R. 7839, Continuing Access to In Home IVIG Act.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to COVID-19 testing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
AMERICAN DENTAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; issues involving implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to the provider relief fund; issues involving H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 1379, Ensuring Lasting Smiles Act.
Issues regarding dental services in Medicare. H.R. 3935, Protecting Patients Transportation to Care Act.
Filing targets: Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related to drug pricing and drug shortages. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act; issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act.
Monitored issues related to prescription drug pricing. Issues related to CAR T-cell therapy reimbursement. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act, as it relates to accelerated payments and Medicaid DSH. H.R. 7791, Value in Health Care Act of 2020. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to provider funding.
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. H.R. 2710 / S.2751, Patient Access to ESRD New Innovative Devices Act, S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the strategic national stockpile. Issues related to home dialysis and the Presidents Advancing American Kidney Health Initiative (AAKHI), and the ESRD Treatment Choices model. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 925 / H.R. 8406, The HEROES Act. Monitored S. 4317, SAFE TO WORK Act. Monitored S. 4322, Safely Back to School and Back to Work Act.
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710 / S. 2751, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health Initiative (AAKHI).
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to Medicare Advantage and issues related to price transparency. Issues related to the Executive Order on Lowering Drug Prices by Putting America First. Issues related to H.R. 7839, Continuing Access to In Home IVIG Act.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to testing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Issues related to the Executive Order on Lowering Drug Prices by Putting America First. H.R. 7839, Continuing Access to In-Home IVIG Act.
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act, as it relates to providers and health plans.
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
Issues related to drug pricing and pass through payment; issues related to disposable negative pressure wound therapy; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues pertaining to administration of anesthesia services for veterans; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
MYRIAD GENETICS, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to S. 3404, VALID Act. Monitored issues related to the implementation of P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act; issues related to EKRA; H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act, issues related to COVID-19 testing and provider relief.
S 3404, VALID Act and regulation of pharmcogenomic tests.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORTHO-CLINICAL DIAGNOSTICS, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Implementation of issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); funding issues related to antibody & antigen tests for COVID-19; H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act, issues related to COVID testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to consumer-directed health care coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to price transparency; issues related to rural hospitals; issues related to Medicaid DSH payments; implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). S. 2543, The Prescription Drug Pricing Reduction Act of 2019.
Issues related to OSHA and hospitals.
Issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act.
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DENTAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues regarding dental services in Medicare. Issues involving dentists and the CARES Act provider relief fund.
Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act.
Filing targets: Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored issues related to drug pricing. Issues related to the corona virus.
Monitored issues related to prescription drug pricing. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. Issues involving promoting plasma donation and convalescent plasma donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis and the Presidents Advancing American Kidney Health initiative (AAKHI). Issues regarding urgent start dialysis.
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health initiative (AAKHI). Issues regarding urgent start dialysis.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
ACCENTURE LLP via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues regarding workforce training programs.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Monitored issues related to prescription drug pricing. Issues related to CAR T-cell therapy reimbursement. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. Issues related to the coronavirus.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
ORTHO-CLINICAL DIAGNOSTICS, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Implementation of issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to antibody tests for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
SMITH & NEPHEW, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to the regulation of medical devices.
Monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MYRIAD GENETICS, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
S 3404, VALID Act and regulation of pharmcogenomic tests.
Issues related to S. 3404, VALID Act. Monitored issues related to the implementation of P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act; issues related to EKRA.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to S. 2543, The Prescription Drug Pricing Reduction Act of 2019 and including Part D and Part B; issues related to the reimbursement of CAR-T therapy; issues related to foreign drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies.
Issues related to Medicare Advantage and issues related to price transparency.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to drug pricing; monitored issues related to S. 1895, Lower Health Care Costs Act of 2019; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality; issues related to vaccines and liability.
Monitored issues related to biosimilars; S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting.
Monitored issues related to H.R. 7120, the George Floyd Justice in Policing Act, and S. 3985, the JUSTICE Act.
UCB, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to the reimbursement of Part B and D drugs; issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the COVID-19 access to Part B drugs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to consumer-directed health care coverage.
Filing targets: Health & Human Services, Dept of (HHS)
ORTHO-CLINICAL DIAGNOSTICS, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · RR
Issues related to COVID-19 and antibody testing.
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to prescription drug pricing. Issues related to CAR T-cell therapy reimbursement. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. Issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home. Coronavirus Aid, Relief & Economic Security Act "CARES Act," P.L. 116-136, as it relates to home dialysis and urgent start dialysis.
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis. Coronavirus Aid, Relief & Economic Security Act "CARES Act," P.L. 116-136, as it relates to home dialysis and urgent start dialysis.
AMERICAN DENTAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues regarding dental services in Medicare. Monitored H.R. 1393, Medicare Dental, Vision, and Hearing Benefit Act. H.R. 3, the Lower Drug Costs Now Act. Issues related to H.R.3935, the Protecting Patients Transportation to Care Act.
Issues regarding access to dental services. Monitored H.R. 1835, Consensual Donation and Research Integrity Act of 2019. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. S.2740 / H.R.3443, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019. Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136, as it relates to over-the-counter monograph safety and surprise billing. Monitored issues related to Indian Health Services. H.R.1379, the Ensuring Lasting Smiles Act. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. Monitored issues related to H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019. Monitored issues related to Section 1557 of the Patient Protection and Affordable Care Act.
ACCENTURE LLP via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues regarding workforce training programs.
Filing targets: Federal Emergency Management Agency (FEMA)
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to price transparency; issues related to rural hospitals; issues related to Medicaid DSH payments; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). S. 2543, The Prescription Drug Pricing Reduction Act of 2019.
Issues related to 42 CFR Part 2; monitored issues regarding drug pricing; issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to S. 1895, Lower Health Care Costs Act of 2019. Monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues related to S. 2543, The Prescription Drug Pricing Reduction Act of 2019 and including Part D and Part B; issues related to the IPI CMMI demonstration; monitored issues related to H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; issues related to the reimbursement of CAR-T therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JUUL LABS, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · 1T
Monitored issues related to implementation of an increase in the minimum age for purchasing tobacco products; education to reduce tobacco consumption.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Issues related to implementation of the Tax Cut and Jobs Act regarding interest expensing; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices. Monitored H.R. 2113, Prescription Drug STAR Act, as it relates to sample device products.
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to transparency and consumer-directed health care coverage. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to S. 1895, Lower Health Care Costs Act of 2019.
S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to the reimbursement of Part B and D drugs; and H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MYRIAD GENETICS, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to regulation of pharmcogenomic tests.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to the safe harbor protection. S. 2543 The Prescription Drug Pricing Reduction Act of 2019; issues related to Medicare Advantage; issues related to Price Transparency; issues related to H.R. 3, the Elijah E. Cummings Lower Cost Act of 2019.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency. Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to drug pricing including S. 2543 Prescription Drug pricing Act and issues related to value based payment over time; H.R. 5882 the GENE Therapy Payment Act; H.R. 3 Elijah E. Cummings lower drug costs act; issues related to Medicaid Best Price and AMP reporting. Issues related to H.R. 3935, the Protecting Patients Transportation to Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to drug pricing and transparency; issues related to S. 1895, Lower Health Care Costs Act of 2019; S. 340, CREATES Act of 2019; issues related to the regulation of cosmetics; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality.
Issues related to biosimilars; S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
H.R. 1158, the Consolidated Appropriations Act of 2020; H.R. 1865, Further Consolidated Appropriations Act, 2020, as it relates to the self-administered drug list.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and S. 1895, Lower Health Care Costs Act of 2019, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
Issues related to biosimilars; H.R. 2296, the METRIC Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
Issues related to drug pricing and transparency; issues related to S. 1895, Lower Health Care Costs Act of 2019; S. 340, CREATES Act of 2019; issues related to the regulation of cosmetics.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
Monitor implementation of The Tax Cut and Jobs Act as it relates to corporate tax reform and the taxation of U.S. multinational corporations. S. 692, Protect Medical Innovation Act of 2019 and H.R. 3301, Taxpayer Certainty and Disaster Tax Relief Act of 2019, as they relate to the medical device tax. H.R. 1865, Further Consolidated Appropriations Act, 2020, as it relates to repeal of the medical device excise tax.
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home.
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
Issues related to transparency and consumer-directed health care coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
Issues related to S. 2543, The Prescription Drug Pricing Reduction Act of 2019 and including Part D and Part B; issues related to the IPI CMMI demonstration; monitored issues related to H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 2296, The METRIC Act; issues related to S. 1895, Lower Health Care Costs Act of 2019.
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
H.R. 1865, Further Consolidated Appropriations Act, 2020 and H.R. 1158, the Consolidated Appropriations Act of 2020.
Issues related to 42 CFR Part 2; monitored issues regarding drug pricing; issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. H.R. 3630, No Surprises Act.
Monitored issues related to price transparency; issues related to rural hospitals; issues related to Medicaid DSH payments; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund and sequestration relief. H.R. 1868, Medicare Sequester Bill, S. 748, Medicare Sequester Relief Act, as it relates to sequestration relief for hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to S. 3404, VALID Act. Monitored issues related to the implementation of P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act; issues related to EKRA; H.R. 925 / H.R. 8406, The HEROES Act, issues related to COVID-19 testing and provider relief. H.R. 133, the Consolidated Appropriations Act of 2021, including surprise medical bill and COVID-19 testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE, White House Office
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Monitor implementation of The Tax Cut and Jobs Act as it relates to corporate tax reform and the taxation of U.S. multinational corporations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Monitored issues related to prescription drug pricing. Issues related to CAR T-cell therapy reimbursement. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office